CAMBER CAPITAL MANAGEMENT LLC 13D and 13G filings for Puma Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 08:34 am Sale | 2024-12-31 | 13G | PUMA BIOTECHNOLOGY INC PBYI | CAMBER CAPITAL MANAGEMENT LLC | 0 0.000% | -2,805,000 (Position Closed) | Filing |
| 2024-02-14 08:19 am Sale | 2023-12-31 | 13G | PUMA BIOTECHNOLOGY INC PBYI | CAMBER CAPITAL MANAGEMENT LLC | 2,805,000 5.900% | -1,430,000 (-33.77%) | Filing |
| 2023-02-14 08:30 am Purchase | 2022-12-31 | 13G | PUMA BIOTECHNOLOGY INC PBYI | CAMBER CAPITAL MANAGEMENT LLC | 4,235,000 9.280% | 2,185,000 (+106.59%) | Filing |